HOME     |     CONTACT


Search  

EastGen News

SEMEX ANNOUNCES JON SCHEFERS NAMED US GENERAL MANAGER
Semex Is Pleased To Announce The Appointment of Jon Schefers as the US General Manager, Effectiv...
NEOGEN® AND SEMEX® PARTNER TO DELIVER SEMEX’S IMMUNITY TECHNOLOGY FOR HEALTHIER HERDS
Neogen Corporation and Semex announced today their partnership to deliver Semex’s Immunity Te...
SEMEX ANNOUNCES RYAN LETT SUCCEEDS DAVID MAYO AT SEMEX NEW ZEALAND
Semex is pleased to announce that Ryan Lett will succeed David Mayo as General Manager of Semex N...
BOVITEQ ANNOUNCES NEW LAB & SATELLITE AT ARIZONA DAIRY COMPANY
Boviteq is thrilled to announce opening a cutting-edge OPU (Oocyte Pick-Up) satellite facility and ...
SEMEX 2025-2026 BOARD OF DIRECTORS ANNOUNCED
Semex is pleased to announce its 2025-2026 Board of Directors. Jean-François Morin (CIAQ) wi...
BOVITEQ ANNOUNCES NEW LICENSEE IN JAPAN
Boviteq is pleased to announce that Nosawa, a longstanding partner of Semex for over 40 years, will...

View All Articles
SEMEX RESEARCH COLLABORATOR DR BONNIE MALLARD WINS UNIVERSITY OF GUELPH NSERC SYNERGY AWARD
Article posted on November 17, 2021, 16:41:31

Semex is pleased to announce that Dr Bonnie Mallard, University of Guelph Professor Ontario Veterinary College, has received the Natural Sciences and Engineering Research Council of Canada (NSERC) Synergy Award and its highest prize of $200,000 towards continuing research. 



Launched in 1995 by NSERC the Synergy Award recognizes partnerships in natural sciences and engineering research and development between universities and Canadian industry. Since their inception, the Awards have honoured the most outstanding achievements of these collaborations in the natural sciences and engineering. 



“When I learned of this win, I was over the moon about this tremendous recognition of my lifetime work as a scientist and professor of immunogenetics,†said Dr. Mallard, adding that the award recognizes women scientists’ ability to translate science into innovation.

“The NSERC Synergy Award for Innovation is one of the highest awards this country offers for innovation, and I plan to use this platform to bring further expansion to the HIR/Immunity+® technology,†she said. “There is still much exciting work left to do.â€

Licensed to Semex, the HIR technology has been available to clients worldwide under the Immunity+ lineup since 2012.

“The HIR technology and Immunity+ is a good example of the importance of long-term research collaborations,†says Paul Larmer, Semex CEO. “Nominations are judged on partnership, effective use of resources and tangible benefits, all of which are evident with Immunity+ and HIR testing. We congratulate Dr. Mallard and we’re excited to continue our work together to reduce cattle disease and its related costs through preventative genetic methods worldwide.â€Â 



Print this Article | Email this Article